Patch Based Wound Healing Products Market To Reach $1.76 Billion By 2030

Patch Based Wound Healing Products Market Growth & Trends

The global patch based wound healing products market size is expected to reach USD 1.76 billion by 2030, registering a CAGR of 4.1% from 2024 to 2030, according to a new report by Grand View Research, Inc. Factors such as increasing prevalence of acute and chronic wounds, number of surgical procedures, incidence of road accidents, and demand for rapid wound healing products are expected to propel the market growth.

Increasing cases of chronic and acute wounds across the globe is anticipated to be the major growth driver for the market. As per a journal published by the ScienceDirect in 2018, prevalence of non-healing chronic wounds in the developed countries is around 1.0 to 2.0% of the population. Adoption of unhealthy and sedentary lifestyles, alcohol consumption, and smoking are some of the major factors contributing to the rise in prevalence of non-communicable diseases.

According to the National Diabetes Statistic Report, 2017, published by the Centers for Disease Control and Prevention (CDC), more than 100 million people in U.S. were living with diabetes or prediabetes in the same year. According to a report published by the American Diabetes Association in 2018, the annual incidence of diabetic foot ulcer was around 2.0% in most Western countries. Rising prevalence of acute wounds across the globe is anticipated to drive the patch based wound healing products market. As per the World Health Organization (WHO), over 1,000,000 people are registered, annually, as moderately or severely burnt. Rising incidence of burns is also anticipated to propel the product demand over the forecast period.

 Request a free sample copy or view report summary: Patch Based Wound Healing Products Market Report

Patch Based Wound Healing Products Market Report Highlights

• Collagen dominated the market and accounted for a share of 35.2% in 2023 due to its superior wound-healing properties and biocompatibility.

• Silver is expected to register a CAGR of 4.6% during the forecast period due to silver's antimicrobial properties, which help prevent infections in wound care.

• The acute wounds segment dominated the market in 2023 pertaining to the rising incidence of injuries from accidents, surgeries, and medical procedures requiring immediate wound care.

• The chronic wound segment is projected to grow at a CAGR of 4.3% over the forecast period. This is attributed to the rising prevalence of conditions such as diabetes and venous ulcers, which increases the need for specialized wound care solutions.

• North America patch based wound healing products market dominated with a share of 45.5% in 2023 due to its advanced healthcare infrastructure and high adoption of innovative wound care technologies.

• Asia Pacific patch based wound healing products market is anticipated to witness significant growth in the forecast period.

Patch Based Wound Healing Products Market Segmentation

Grand View Research has segmented global patch based wound healing products market report based on formulation, application, and region:

Patch Based Wound Healing Products Formulation Outlook (Revenue, USD Million, 2018 - 2030)

• Povidone-iodine

• Silver

• Collagen

• Others

Patch Based Wound Healing Products Application Outlook (Revenue, USD Million, 2018 - 2030)

• Acute Wounds

• Chronic Wounds

Patch Based Wound Healing Products Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East and Africa (MEA)

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players of Patch Based Wound Healing Products Market

• Smith+Nephew

• Mölnlycke AB

• Coloplast

• B. Braun SE

• 3M

• MIMEDX Group, Inc.

• Medtronic

• Convatec Inc.

• INTEGRA LIFESCIENCES

• Organogenesis Inc